These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cross sensitivity in colour developers. Goh CL; Kwok SF; Rajan VS Contact Dermatitis; 1984 May; 10(5):280-5. PubMed ID: 6734190 [TBL] [Abstract][Full Text] [Related]
3. [Lichenoid contact eczema caused by color film developer]. Schoel J; Tilgen W; Frosch PJ Hautarzt; 1991 Apr; 42(4):251-3. PubMed ID: 1830569 [TBL] [Abstract][Full Text] [Related]
4. [CONTACT DERMATITIS OF THE LICHEN PLANUS TYPE CAUSED BY PHOTOGRAPHIC DEVELOPERS. FIRST CASES IN BRAZIL]. ROTBERG A; PEREIRA CA An Bras Dermatol; 1965; 40():1-6. PubMed ID: 14322355 [No Abstract] [Full Text] [Related]
9. Assessment of colour vision impairment in male workers exposed to toluene generally above occupational exposure limits. Zavalic M; Mandic Z; Turk R; Bogadi-Sare A; Plavec D; Gomzi M; Skender LJ Occup Med (Lond); 1998 Apr; 48(3):175-80. PubMed ID: 9659727 [TBL] [Abstract][Full Text] [Related]
10. Occupational exposure to benzene, toluene and xylene and the lymphocyte lysosomal N-acetyl-beta-D-glucosaminidase. Moszczyński P; Lisiewicz J Ind Health; 1985; 23(1):47-51. PubMed ID: 3997566 [No Abstract] [Full Text] [Related]
11. [Multiple episodes of eczema of the hands caused by sensitization to amino-azotoluene]. Castelain PY Bull Soc Fr Dermatol Syphiligr; 1967; 74(5):561. PubMed ID: 5587876 [No Abstract] [Full Text] [Related]
12. Colour vision and occupational toluene exposure: results of repeated examinations. Schäper M; Demes P; Kiesswetter E; Zupanic M; Seeber A Toxicol Lett; 2004 Jun; 151(1):193-202. PubMed ID: 15177654 [TBL] [Abstract][Full Text] [Related]
14. Dose-dependent increase in subjective symptom prevalence among toluene-exposed workers. Lee BK; Lee SH; Lee KM; Cho KS; Ahn KD; Kim SB; Ukai H; Nakatsuka H; Watanabe T; Ikeda M Ind Health; 1988; 26(1):11-23. PubMed ID: 3360616 [No Abstract] [Full Text] [Related]
16. [Urinary hippuric acid excretion rate in evaluating occupational toluene exposure]. Gutewort T; Gartzke J; Pannier R Z Gesamte Hyg; 1981; 27(1):57-63. PubMed ID: 7269678 [No Abstract] [Full Text] [Related]
17. Skin disease from colour developers. De Graciansky P; Boulle S Br J Dermatol; 1966 May; 78(5):297-8. PubMed ID: 4223005 [No Abstract] [Full Text] [Related]
18. [Exposure to imipramine and toluene in the pharmaceutical industry. Risk of toxic interaction in the liver]. Trevisan A; Caroldi S; Rosa A; Chiesura P Med Lav; 1979; 70(2):105-8. PubMed ID: 470811 [No Abstract] [Full Text] [Related]
19. [Behavior of urinary hippuric acid in non-occupationally exposed subjects and in workers with moderate exposure to toluene]. Alessio L; Odone P; Rivolta G; Soma R; Confortini C; Colombi A Med Lav; 1981; 72(1):38-45. PubMed ID: 7242443 [No Abstract] [Full Text] [Related]
20. [Occupational skin diseases in the chemical industry]. GOLDMANN P Z Haut Geschlechtskr; 1963 Jun; 34():355-68 contd. PubMed ID: 13948790 [No Abstract] [Full Text] [Related] [Next] [New Search]